Preoperative Chemoradiation for Pancreatic Adenocarcinoma Does Not Increase 90-Day Postoperative Morbidity or Mortality
出版年份 2016 全文链接
标题
Preoperative Chemoradiation for Pancreatic Adenocarcinoma Does Not Increase 90-Day Postoperative Morbidity or Mortality
作者
关键词
Chemoradiation, Pancreatic adenocarcinoma, Pancreatectomy, Pancreatic fistula, Morbidity
出版物
JOURNAL OF GASTROINTESTINAL SURGERY
Volume 20, Issue 12, Pages 1975-1985
出版商
Springer Nature
发表日期
2016-10-12
DOI
10.1007/s11605-016-3286-9
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Pancreatic Adenocarcinoma, Version 2.2014
- (2017) Margaret A. Tempero et al. Journal of the National Comprehensive Cancer Network
- Impact of hypofractionated and standard fractionated chemoradiation before pancreatoduodenectomy for pancreatic ductal adenocarcinoma
- (2016) Jordan M. Cloyd et al. CANCER
- Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline
- (2016) Alok A. Khorana et al. JOURNAL OF CLINICAL ONCOLOGY
- Neoadjuvant Radiotherapy: A Risk Factor for Short-Term Wound Complications after Radical Resection for Rectal Cancer?
- (2016) Stefan D. Holubar et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Comparing the burden of pancreatic fistulas after pancreatoduodenectomy and distal pancreatectomy
- (2016) Matthew T. McMillan et al. SURGERY
- Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma
- (2015) Eric A. Mellon et al. ACTA ONCOLOGICA
- Active Surveillance for Adverse Events Within 90 Days: The Standard for Reporting Surgical Outcomes After Pancreatectomy
- (2015) Lilian Schwarz et al. ANNALS OF SURGICAL ONCOLOGY
- Neoadjuvant Radiation Therapy Prior to Total Mesorectal Excision for Rectal Cancer is Not Associated with Postoperative Complications Using Current Techniques
- (2014) Sarah A. Milgrom et al. ANNALS OF SURGICAL ONCOLOGY
- The 90-Day Mortality After Pancreatectomy for Cancer Is Double the 30-Day Mortality: More than 20,000 Resections From the National Cancer Data Base
- (2014) Richard S. Swanson et al. ANNALS OF SURGICAL ONCOLOGY
- Randomized clinical trial of pancreaticogastrostomyversuspancreaticojejunostomy on the rate and severity of pancreatic fistula after pancreaticoduodenectomy
- (2014) J. Figueras et al. BRITISH JOURNAL OF SURGERY
- Preoperative chemoradiation therapy for esophageal cancer is a risk factor for the elevation of high mobility group box-1, leading to an increase in postoperative severe pulmonary complications
- (2014) R. Takahata et al. DISEASES OF THE ESOPHAGUS
- Does the Use of Neoadjuvant Therapy for Pancreatic Adenocarcinoma Increase Postoperative Morbidity and Mortality Rates?
- (2014) Amanda B. Cooper et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Postpancreatectomy Hemorrhage—Incidence, Treatment, and Risk Factors in Over 1,000 Pancreatic Resections
- (2014) U. F. Wellner et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Using a modification of the Clavien-Dindo system accounting for readmissions and multiple interventions: Defining quality for pancreaticoduodenectomy
- (2014) Marshall S. Baker et al. JOURNAL OF SURGICAL ONCOLOGY
- Neoadjuvant chemoradiation therapy with gemcitabine/cisplatin and surgery versus immediate surgery in resectable pancreatic cancer
- (2014) Henriette Golcher et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Neoadjuvant Chemoradiation and Duration of Chemotherapy Before Surgical Resection for Pancreatic Cancer: Does Time Interval Between Radiotherapy and Surgery Matter?
- (2013) Kathryn T. Chen et al. ANNALS OF SURGICAL ONCOLOGY
- Understanding Hospital Readmissions After Pancreaticoduodenectomy: Can We Prevent Them?
- (2013) Zhi Ven Fong et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Final Results of a Safety and Efficacy Trial of Preoperative Sequential Chemoradiation Therapy for the Nonsurgical Treatment of Early Breast Cancer: Japan Clinical Oncology Group Study JCOG0306
- (2013) Hirofumi Mukai et al. ONCOLOGY
- Does pre‐operative chemoradiation for initially unresectable or borderline resectable pancreatic adenocarcinoma increase post‐operative morbidity? A case‐matched analysis
- (2013) Raphael L.C. Araujo et al. HPB
- Defined Clinical Classifications Are Associated with Outcome of Patients with Anatomically Resectable Pancreatic Adenocarcinoma Treated with Neoadjuvant Therapy
- (2012) Ching-Wei D. Tzeng et al. ANNALS OF SURGICAL ONCOLOGY
- Retroperitoneal Dissection in Patients with Borderline Resectable Pancreatic Cancer: Operative Principles and Techniques
- (2012) Matthew H.G. Katz et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- A Prospectively Validated Clinical Risk Score Accurately Predicts Pancreatic Fistula after Pancreatoduodenectomy
- (2012) Mark P. Callery et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Toward defining grade C pancreatic fistula following pancreaticoduodenectomy: incidence, risk factors, management and outcome
- (2012) Jason W. Denbo et al. HPB
- Effect of Neoadjuvant Chemoradiation and Surgical Technique on Recurrence of Localized Pancreatic Cancer
- (2011) Matthew H. G. Katz et al. JOURNAL OF GASTROINTESTINAL SURGERY
- A Systematic Review and Meta-analysis of Survival and Surgical Outcomes Following Neoadjuvant Chemoradiotherapy for Pancreatic Cancer
- (2011) Jerome Martin Laurence et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Preoperative chemoradiation reduces the risk of pancreatic fistula after distal pancreatectomy for pancreatic adenocarcinoma
- (2011) Hidenori Takahashi et al. SURGERY
- Unresectable Locally Advanced Pancreatic Cancer: A Multimodal Treatment Using Neoadjuvant Chemoradiotherapy (Gemcitabine Plus Stereotactic Radiosurgery) and Subsequent Surgical Exploration
- (2010) Francesco Polistina et al. ANNALS OF SURGICAL ONCOLOGY
- Risk Stratification for Distal Pancreatectomy Utilizing ACS-NSQIP: Preoperative Factors Predict Morbidity and Mortality
- (2010) Kaitlyn Jane Kelly et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages
- (2010) Sonja Gillen et al. PLOS MEDICINE
- Combined Modality Treatment of Resectable and Borderline Resectable Pancreas Cancer: Expert Consensus Statement
- (2009) Ross A. Abrams et al. ANNALS OF SURGICAL ONCOLOGY
- Preoperative Gemcitabine and Cisplatin Followed by Gemcitabine-Based Chemoradiation for Resectable Adenocarcinoma of the Pancreatic Head
- (2008) Gauri R. Varadhachary et al. JOURNAL OF CLINICAL ONCOLOGY
- Preoperative Gemcitabine-Based Chemoradiation for Patients With Resectable Adenocarcinoma of the Pancreatic Head
- (2008) Douglas B. Evans et al. JOURNAL OF CLINICAL ONCOLOGY
- Borderline Resectable Pancreatic Cancer: The Importance of This Emerging Stage of Disease
- (2008) Matthew H.G. Katz et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started